Boston Trust Walden’s AstraZeneca AZN Stock Holding History

Boston Trust Walden’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,736	Closed	-$382K	–	393
2025 Q2	$382K	Hold	2,736	–	–	﹤0.01%	334
2025 Q1	$402K	Hold	2,736	–	–	﹤0.01%	325
2024 Q4	$358K	Sell	2,736 -347	-11%	-$48.6K	﹤0.01%	339
2024 Q3	$480K	Buy	3,083 +355	+13%	+$57.3K	﹤0.01%	320
2024 Q2	$425K	Buy	2,728 +28	+1%	+$4.21K	﹤0.01%	328
2024 Q1	$366K	Hold	2,700	–	–	﹤0.01%	335
2023 Q4	$364K	Hold	2,700	–	–	﹤0.01%	330
2023 Q3	$366K	Hold	2,700	–	–	﹤0.01%	319
2023 Q2	$386K	Hold	2,700	–	–	﹤0.01%	322
2023 Q1	$375K	Hold	2,700	–	–	﹤0.01%	325
2022 Q4	$366K	Hold	2,700	–	–	﹤0.01%	326
2022 Q3	$296K	Hold	2,700	–	–	﹤0.01%	327
2022 Q2	$357K	Hold	2,700	–	–	﹤0.01%	326
2022 Q1	$358K	Hold	2,700	–	–	﹤0.01%	335
2021 Q4	$315K	Hold	2,700	–	–	﹤0.01%	356
2021 Q3	$324K	Hold	2,700	–	–	﹤0.01%	347
2021 Q2	$323K	Hold	2,700	–	–	﹤0.01%	351
2021 Q1	$268K	Hold	2,700	–	–	﹤0.01%	350
2020 Q4	$270K	Hold	2,700	–	–	﹤0.01%	353
2020 Q3	$296K	Hold	2,700	–	–	﹤0.01%	340
2020 Q2	$286K	Hold	2,700	–	–	﹤0.01%	338
2020 Q1	$241K	Hold	2,700	–	–	﹤0.01%	334
2019 Q4	$269K	Hold	2,700	–	–	﹤0.01%	356
2019 Q3	$241K	Hold	2,700	–	–	﹤0.01%	363
2019 Q2	$223K	Hold	2,700	–	–	﹤0.01%	368
2019 Q1	$218K	Hold	2,700	–	–	﹤0.01%	370
2018 Q4	$205K	Hold	2,700	–	–	﹤0.01%	367
2018 Q3	$214K	Buy	+2,700	New	+$204K	﹤0.01%	372
2014 Q3	–	Sell	-2,700	Closed	-$201K	–	336
2014 Q2	$201K	Buy	+2,700	New	+$195K	﹤0.01%	335

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Boston Trust Walden's AZN Position: Q3 2025 in Review

Boston Trust Walden sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 2,736 shares — an estimated $382K sold.

Boston Trust Walden first reported a position in AZN in Q2 2014 and held it in 29 quarters. The position peaked at $480K in Q3 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Boston Trust Walden reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
Boston Trust Walden sold 2,736 AstraZeneca shares in Q3 2025, an estimated $382K.
Boston Trust Walden first reported a position in AstraZeneca in Q2 2014 and held it in 29 quarters.
Boston Trust Walden's AstraZeneca position peaked at $480K in Q3 2024.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Boston Trust Walden's 13F filing for Q3 2025, filed 17 Oct 2025.